![Roy C. Cosan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roy C. Cosan
Direttore/Membro del Consiglio presso
RealBio Technology, Inc.
Profilo
Mr. Roy C.
Cosan is a Managing Director at Fjord Ventures LLC.
He is on the Board of Directors at RealBio Technology, Inc.
Mr. Cosan's experience includes 32 years with Johnson and Johnson.
He was Vice President of New Product Development at Janssen Pharmaceutica where he launched Risperdal and Reminly.
He was also a Vice President with the Johnson & Johnson Development Corp., the venture capital arm of J&J where he invested in 19 companies and held 11 board of director seats.
At J&J, he also built a virtual R&D capability for the J&J Pharma organization.
Mr. Cosan received his undergraduate degree from Western Michigan University.
Posizioni attive di Roy C. Cosan
| Società | Posizione | Inizio |
|---|---|---|
RealBio Technology, Inc.
 RealBio Technology, Inc. Medical SpecialtiesHealth Technology Develops cell and tissue culture technologies | Direttore/Membro del Consiglio | 18/05/2010 |
Fjord Ventures Inc
 Fjord Ventures Inc Investment ManagersFinance Fjord Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life sciences sectors. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/02/2010 |
Precedenti posizioni note di Roy C. Cosan
| Società | Posizione | Fine |
|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Analista di Private Equity | 31/12/2008 |
Galileo Pharmaceuticals, Inc.
 Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and pharmaceuticals | Direttore/Membro del Consiglio | 16/12/2008 |
TorreyPines Therapeutics, Inc. /Old/
 TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Direttore/Membro del Consiglio | 06/10/2006 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 31/12/1999 |
Renova Therapeutics, Inc.
 Renova Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of gene and peptide therapies | Presidente | - |
Formazione di Roy C. Cosan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
45
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
RealBio Technology, Inc.
RealBio Technology, Inc. Medical SpecialtiesHealth Technology Develops cell and tissue culture technologies | Health Technology |
Metronom Health, Inc.
 Metronom Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and markets continuous glucose monitoring systems for diabetes management | Electronic Technology |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and pharmaceuticals | Health Technology |
Western Michigan University
 Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TorreyPines Therapeutics, Inc. /Old/
TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Fjord Ventures Inc
Fjord Ventures Inc Investment ManagersFinance Fjord Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life sciences sectors. It provides financing for early stage capital requirements. | Finance |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of gene and peptide therapies | Health Technology |
Prelude Corp.
 Prelude Corp. BiotechnologyHealth Technology Develops breast cancer tools to manage early stage breast cancer | Health Technology |
Orchest Health Corp.
 Orchest Health Corp. Electronic Equipment/InstrumentsElectronic Technology Provides glucose monitoring sensors for diabetes | Electronic Technology |
